Homologous recombination proficiency in ovarian and breast cancer patients
BMC Cancer, 2021 Homologous recombination and DNA repair are important for genome maintenance. Genetic variations in essential homologous recombination genes, including BRCA1 and BRCA2 results in homologous recombination deficiency (HRD) and can be a target for ...
Justin Fortune Creeden +7 more
doaj +2 more sources
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
Clinics, 2018 Ovarian cancer patients with homologous recombination deficiencies exhibit specific clinical behaviors, and improved responses to treatments, such as platinum-based chemotherapy and poly (ADP-ribose) polymerase (PARP) inhibitors, have been observed ...
Renata Rodrigues da Cunha Colombo Bonadio +3 more
doaj +2 more sources
Pan-cancer landscape of homologous recombination deficiency
Nature Communications, 2020 Cancers deficient in homologous recombination can benefit from treatment with poly ADP-ribose polymerase (PARP) inhibitors. Here, the authors generated a classifier that can predict homologous recombination deficiency from genomic data and suggest ...
Luan Nguyen +3 more
doaj +2 more sources
Homologous recombination deficiency among patients with germline or somatic non-BRCA1/2 homologous recombination repair gene variations. [PDF]
NPJ Precis OncolThis study examined the relationship between homologous recombination deficiency (HRD) and variations in non-BRCA1/2 homologous recombination repair (HRR) genes.
Li Y, Yang X, Cai H, Wang F.
europepmc +2 more sources
Homologous recombination risk in baculovirus expression vector system
Virus Research, 2022 The baculovirus expression vector system (BEVS) is widely used for producing recombinant proteins. To achieve high expression level of recombinant proteins, baculoviral elements, such as enhancers, promoters, signal peptide coding sequences and 3′-UTR ...
Jianan Huang, Huanlei Liu, Xiaodong Xu
doaj +1 more source
BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality.
Cancer Research, 2023 The concept of "BRCAness" was first described in 2004 to define the situation in which a homologous recombination repair (HRR) defect in a tumor relates to and phenocopies BRCA1 or BRCA2 loss-of-function mutations.
J. Murai, Y. Pommier
semanticscholar +1 more source
Nature Cancer, 2021 DNA polymerase theta (POLθ or POLQ) is synthetic lethal with homologous recombination (HR) deficiency and is thus a candidate target for HR-deficient cancers.
Jia Zhou +13 more
semanticscholar +1 more source
Homologous recombination deficiency: cancer predispositions and treatment implications.
The Oncologist, 2021 Homologous recombination (HR) is a highly accurate DNA repair mechanism. Several HR genes are established cancer susceptibility genes with clinically actionable pathogenic variants (PVs).
M. Toh, J. Ngeow
semanticscholar +1 more source
Homologous Recombination Deficiencies and Hereditary Tumors
International Journal of Molecular Sciences, 2021 Homologous recombination (HR) is a vital process for repairing DNA double-strand breaks. Germline variants in the HR pathway, comprising at least 10 genes, such as BRCA1, BRCA2, ATM, BARD1, BRIP1, CHEK2, NBS1(NBN), PALB2, RAD51C, and RAD51D, lead to ...
H. Yamamoto, Akira Hirasawa
semanticscholar +1 more source
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Genome Medicine, 2023 Background Homologous recombination is a robust, broadly error-free mechanism of double-strand break repair, and deficiencies lead to PARP inhibitor sensitivity.
Daniel H. Jacobson +3 more
doaj +1 more source